Cerebral Edema Clinical Trial
Official title:
Evaluation of the Cerebral Edema With Measurement of Optic Nerve Sheath in Children Having Diabetic Ketoacidosis
The purpose of this study is to determine cerebral edema with evaluation of measurement of diameter of optic nerve sheath.
The purpose of this study is to determine cerebral edema with evaluation of measurement of
diameter of optic nerve sheath. For that, If patients have Fluid treatment shall be started
in 4 hours in our or other Emergency Care, they will be included our study. If not, they will
be out of our study.
How we measure;
1. First measurement shall be taken in 4 hours.
2. Second measurement shall be taken at 12 hours in mild and 12-18 hours measurement shall
be taken for severe diabetic ketoacidosis,
3. Third measurement shall be taken after fluid treatment.
4. Fourth measurement shall be taken at polyclinic control. So, after all measurements will
be hand and all data will be analyzed with statistical program. After that all outcome
will be discussed and compared with patient at normal conditions at their polyclinic
visit.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01954290 -
Study of Stroke Related Edema Treatments
|
Phase 2 | |
| Terminated |
NCT00243022 -
Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme
|
Phase 2 | |
| Recruiting |
NCT05585255 -
Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
|
||
| Completed |
NCT04116138 -
Antisecretory Factor in Primary Glioblastoma 1
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT05725694 -
Acute Ischaemic STROKE: From LAboratory to the Patient's BED
|
||
| Withdrawn |
NCT03330704 -
Small-Volume, Patient-Specific, Balanced Hypertonic Fluid Protocol Validation
|
Early Phase 1 | |
| Completed |
NCT01365793 -
Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis
|
Phase 3 | |
| Completed |
NCT03000283 -
Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study
|
Phase 1 | |
| Active, not recruiting |
NCT06018545 -
AI Assisted Reader Evaluation in Acute Computed Tomography (CT) Head Interpretation
|
||
| Completed |
NCT05796349 -
Study on Data Acquisition and Image Characteristics of Brain Multifrequency EIT in Healthy People and Patients With Brain Diseases
|
||
| Recruiting |
NCT04303065 -
Dexamethasone for the Treatment of Vasogenic Pericontusional Edema.
|
Phase 3 | |
| Withdrawn |
NCT01605357 -
Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04247659 -
Study on the Relationship Between Asymmetric Vascular Sign of Cortex and Prognosis in Massive Cerebral Infarction
|
Phase 4 | |
| Completed |
NCT05060159 -
Conventional Hemodialysis Versus Post-Dilution Hemofiltration in Incident RRT
|
N/A | |
| Completed |
NCT01060969 -
Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention
|
N/A | |
| Recruiting |
NCT03703284 -
Molecular Mechanisms of Malignant Cerebral Edema After LHI
|
||
| Completed |
NCT05200728 -
The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese Volunteers
|
Phase 1 | |
| Withdrawn |
NCT03409237 -
Coagulation Activation by Hyperosmolar Agents in Intracranial Hypertension
|
||
| Not yet recruiting |
NCT06096415 -
Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury
|
Phase 2 | |
| Completed |
NCT02142712 -
Histamine Glutamate Antagonism in Stroke
|
Phase 2 |